Thomas E. Cuddy

TL;DR: In patients with asymptomatic left ventricular dysfunction after myocardial infarction, long-term administration of captopril was associated with an improvement in survival and reduced morbidity and mortality due to major cardiovascular events.

TL;DR: The threshold for the admission of patients to a coronary care unit or for the use of invasive diagnostic and therapeutic interventions in the early and late periods after an infarction is higher in Canada than in the United States, which is associated with a higher frequency of activity-limiting angina.

TL;DR: Although the Survival and Ventricular Enlargement Study population was selected for left ventricular dysfunction, the majority of patients who currently are judged clinically as unsuitable for thrombolytic therapy have a higher risk for adverse cardiovascular events.

TL;DR: The results indicate that, in fact, a subgroup of patients without overt heart failure has persistent neurohumoral activation at the time of hospital discharge postinfarction, and that this activation involves several neurohumological systems.

TL;DR: In this article, the authors developed a risk model to predict heart failure in patients with stable coronary artery disease and preserved ejection fraction using a Cox regression multivariable model using backward selection if P < 0.05.